• L-Phe Nanostructures Sensitize Tumors to ICB

  2026-08-17

  This Nature Nanotechnology study shows that metal-ion-chelating L-phenylalanine nanostructures can reprogram dendritic-cell electrophysiology and remodel immunosuppressive tumor microenvironments. Their combination with short-term starvation enhanced dendritic-cell maturation, tumor-specific cytotoxic T-cell responses, and sensitivity to immune checkpoint blockade in breast and colorectal tumor models.

• Rotenone B5462 for Mitochondrial Assays

  2026-08-16

  Learn how Rotenone (SKU B5462) can standardize mitochondrial stress, cytotoxicity, and apoptosis workflows across neuronal and cardiac cell models. This scenario-based guide connects Complex I inhibition with assay design, solvent handling, data interpretation, and practical product selection.

• Dexamethasone (DHAP): Research Mechanisms & Uses

  2026-08-15

  Dexamethasone (DHAP) is a synthetic glucocorticoid anti-inflammatory research compound used to study NF-κB regulation, stem cell differentiation, autophagy, osteosarcoma biology, and neuroinflammation. Its product-defined identity, solvent compatibility, storage requirement, and model-specific findings support controlled, evidence-bounded workflows rather than universal dosing claims.

• MCC950 sodium: Practical NLRP3 Workflow

  2026-08-14

  MCC950 sodium turns NLRP3 biology into a controllable experimental variable, from H2O2-injured endothelial cells to macrophage and autoimmune disease models. This guide translates a HUVEC pyroptosis study into a reproducible workflow, with assay controls, selectivity logic, and troubleshooting strategies for inflammatory disease research.

• Cimetidine as a Mechanism-Aware BBB Assay Control

  2026-08-14

  Cimetidine is more than a histamine-2 receptor antagonist: it can serve as a carefully qualified probe for separating H2 receptor biology, passive permeability, efflux, and lysosomal trapping. This article translates a 2025 surrogate blood-brain barrier study into a practical framework for cancer research and transport assay design.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-08-13

  The reference study establishes a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. These organoids can be cryopreserved, differentiated into intestinal epithelial cells, and used to examine enterocyte drug-metabolizing enzymes and transporters in a human-relevant pharmacokinetic model.

• Recent Advances in Ibuprofen and Naproxen Synthesis

  2026-08-13

  Ha and Paek review how modern synthetic chemistry has improved the preparation of ibuprofen and naproxen through shorter, more practical, stereoselective, and continuous-flow routes. The study is valuable for researchers because it connects route design with scalability, chiral control, reagent safety, and access to derivatives, while also clarifying what the synthesis literature does not establish about biological performance.

• Sulfo-NHS-LC-Biotin Protocol and QC Guide

  2026-08-12

  Sulfo-NHS-LC-Biotin provides stable, water-compatible biotin labeling of accessible primary amines on proteins, peptides, and intact cell surfaces for downstream avidin or streptavidin capture. It is appropriate for irreversible extracellular or purified-protein labeling, but not for intracellular labeling of intact cells or workflows requiring reversible biotin attachment.

• Budesonide: From Mechanism to Pulmonary Translation

  2026-08-12

  Budesonide offers translational researchers more than a familiar anti-inflammatory benchmark: it provides a mechanistically grounded test compound for connecting glucocorticoid biology, airway inflammation, and pulmonary permeability. This article outlines how biomimetic chromatography can strengthen Budesonide-centered asthma inflammation models while clarifying the limits of physicochemical screening.

• Protoporphyrin IX for Ferroptosis Workflows

  2026-08-11

  Protoporphyrin IX connects heme formation, light-triggered oxidation, and ferroptosis-oriented assay design in one research workflow. This guide shows how to manage its insolubility, separate dark from photodynamic effects, and translate the METTL16-SENP3-LTF findings into stronger hepatocellular carcinoma experiments.

• Polyphyllin H Reverses Paclitaxel Resistance

  2026-08-11

  The reference study identifies membrane cholesterol and lipid rafts as a shared regulatory platform for ABCB1 and ABCC3 in paclitaxel-resistant breast cancer. Its findings support a multi-target resistance strategy in which Polyphyllin H binds cholesterol, reduces drug efflux, and improves paclitaxel response, while also defining experimental priorities for mechanistic validation.

• 2-NBDG for Cellular Glucose Uptake

  2026-08-10

  2-NBDG, also called 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose, is a fluorescent glucose analog for measuring cellular glucose uptake. Its signal supports flow cytometry, fluorescence microscopy, and microplate glucose metabolism assays, but it should not be interpreted as a direct measurement of glycolytic flux.

• PPARγ, Macrophage Polarization, and DSS Colitis

  2026-08-09

  The reference study identifies PPARγ activation as a regulator of macrophage-state balance in dextran sulfate sodium-induced inflammatory bowel disease, linking reduced M1 signaling and enhanced M2 signaling to the STAT-1/STAT-6 pathway. Its combined cell and mouse experiments provide a mechanistic framework for studying intestinal inflammation, while also highlighting the limits of translating pharmacological PPARγ modulation beyond the tested model.

• HotStart™ 2X Green qPCR Master Mix Guide

  2026-08-08

  HotStart™ 2X Green qPCR Master Mix supports SYBR Green real-time PCR for cDNA or DNA quantification when nonspecific amplification, primer-dimers, and inconsistent setup are concerns. It is appropriate for gene expression analysis and RNA-seq validation, but it does not replace reverse transcription or provide sequence-specific discrimination like a probe assay.

• Lipo3K Transfection Reagent for Kidney Assays

  2026-08-07

  Lipo3K Transfection Reagent supports low-toxicity delivery of plasmid DNA, siRNA, and mRNA in demanding kidney and organoid workflows. Its enhancer-assisted DNA delivery, serum compatibility, and flexible collection window make it a practical lipofectamine alternative for mechanistic gene expression studies and RNA interference research.

555 records 8/37 page Previous Next First page 上5页 678910 下5页 Last page